"Blood Glucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glucose in blood.
| Descriptor ID |
D001786
|
| MeSH Number(s) |
D09.947.875.359.448.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Blood Glucose".
Below are MeSH descriptors whose meaning is more specific than "Blood Glucose".
This graph shows the total number of publications written about "Blood Glucose" by people in this website by year, and whether "Blood Glucose" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 2 | 2 | 4 |
| 1998 | 1 | 3 | 4 |
| 1999 | 3 | 2 | 5 |
| 2000 | 2 | 3 | 5 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 4 | 5 |
| 2003 | 1 | 3 | 4 |
| 2004 | 2 | 8 | 10 |
| 2005 | 2 | 2 | 4 |
| 2006 | 2 | 2 | 4 |
| 2007 | 2 | 7 | 9 |
| 2008 | 6 | 6 | 12 |
| 2009 | 5 | 3 | 8 |
| 2010 | 10 | 9 | 19 |
| 2011 | 3 | 8 | 11 |
| 2012 | 5 | 13 | 18 |
| 2013 | 2 | 14 | 16 |
| 2014 | 2 | 11 | 13 |
| 2015 | 4 | 10 | 14 |
| 2016 | 1 | 10 | 11 |
| 2017 | 5 | 10 | 15 |
| 2018 | 6 | 8 | 14 |
| 2019 | 6 | 8 | 14 |
| 2020 | 1 | 5 | 6 |
| 2021 | 4 | 4 | 8 |
| 2022 | 1 | 6 | 7 |
| 2023 | 2 | 3 | 5 |
| 2024 | 2 | 4 | 6 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood Glucose" by people in Profiles.
-
LaRovere KL, Asaro LA, Coughlin-Wells K, Nadkarni VM, Agus MSD. Blood Glucose Range for Hyperglycemic PICU Children With Primary Neurologic Diagnoses: Analysis of the Heart and Lung Failure-Pediatric Insulin Titration (HALF-PINT) Trial. Pediatr Crit Care Med. 2025 Apr 01; 26(4):e432-e446.
-
Simonson DC, Testa MA, Ekholm E, Su M, Vilsb?ll T, Jabbour SA, Lind M. Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine. J Clin Endocrinol Metab. 2024 11 18; 109(12):e2261-e2272.
-
Brownlee HA, Soriano EC, Lenhard MJ, Fenech AL, Morreale M, Siegel SD, Bolger N, Laurenceau JP. Romantic relationships and type 2 diabetes: The role of invisible social control. Health Psychol. 2024 Oct; 43(10):739-746.
-
Jabbour S, Paik JS, Aleppo G, Sharma P, Gomez Valderas E, Benneyworth BD. Switching to Tirzepatide 5?mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment. Endocr Pract. 2024 Aug; 30(8):701-709.
-
Wai KM, Mishra K, Koo E, Ludwig CA, Parikh R, Mruthyunjaya P, Rahimy E. Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study. Am J Ophthalmol. 2024 09; 265:39-47.
-
Parkman HP, Rim DS, Anolik JR, Dadparvar S, Maurer AH. Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the Ugly-Benefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying. J Nucl Med Technol. 2024 Mar 05; 52(1):3-7.
-
Varney MJ, Benovic JL. The Role of G Protein-Coupled Receptors and Receptor Kinases in Pancreatic ?-Cell Function and Diabetes. Pharmacol Rev. 2024 02 13; 76(2):267-299.
-
Khan AZ, Vaughan A, Mandava NK, Wickes C, Ramsey ML, Namdari S. Elevated HbA1c is not associated with reoperation following arthroscopic rotator cuff repair in patients with diabetes mellitus. J Shoulder Elbow Surg. 2024 Feb; 33(2):247-254.
-
Zinter MS, Markovic D, Asaro LA, Nadkarni VM, McQuillen PS, Sinha P, Matthay MA, Jeschke MG, Agus MSD, Sapru A. Tight Glycemic Control, Inflammation, and the ICU: Evidence for Heterogeneous Treatment Effects in Two Randomized Controlled Trials. Am J Respir Crit Care Med. 2023 04 01; 207(7):945-949.
-
Estock JL, Codario RA, Keddem S, Zupa MF, Rodriguez KL, DiNardo MM. Insulin Pump-Associated Adverse Events: A Qualitative Descriptive Study of Clinical Consequences and Potential Root Causes. Diabetes Technol Ther. 2023 05; 25(5):343-355.